✦ LIBER ✦

PCN113 Cost-Utility Analysis of Combination Therapy of Pegylated Liposomal Doxorubicin(PLD) and Carboplatin for Korean Women with Platinum-Sensitive Ovarian Cancer

✍ Scribed by Lee, H.Y.; Hong, J.M.; Yang, B.M.; Lee, T.J.; Kim, B.G.; Kang, S.B.; Kim, Y.T.; Kim, Y.M.; Kim, J.W.; Yang, J.M.; Jung, Y.J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of carboplatin and distea

✍ Sheng-Mou Hsiao; Chi-An Chen; Ho-Hsiung Lin; Chang-Yao Hsieh; Lin-Hung Wei 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 166 KB

8050 POSTER Cost-effectiveness of Trabec

✍ Gore, M.; Vergote, I.; Vasanthan, S.; Chan, S.; Arranz, J.M.; Colombo, N.; Arran 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

P273 Non-pegylated liposomal doxorubicin

✍ R. Addeo; L. Montella; G. Cennamo; P. Maione; G. Guerra; M. Bianco; A. Febbraro; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

8029 POSTER Health-Related Quality of Li

✍ Verqote, I.; Bidzinski, M.; Kelley, J.; Vasanthan, S.; Runnebaum, I.; Vermorken, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB